Editorial
Working-group output, perspectives on research-administration standards, news from the CASRAI federation, and substantive long-form on the open-research vocabulary.
Reps. John Moolenaar and Ben Cline asked Acting FDA Commissioner Kyle Diamantas on Aug. 21, 2026 to reject Chinese clinical data absent a recent FDA site audit, after three undisclosed trial deaths surfaced. What sponsors and IRBs relying on China-sourced data should expect next.
The Australian Research Council published a draft FAIR Data Policy on Aug. 11, 2026 for sector feedback, embedding Findable and Accessible requirements into future National Competitive Grants Program schemes. Feedback closes Sept. 16, 2026 — what ARC-funded institutions should check now.
Elsevier told Games and Economic Behavior’s editor-in-chief his six-year term would end in December; all six editors resigned within weeks, and 58 of 62 advisory editors followed by Aug. 19, 2026. What the collapse of a discipline-leading journal’s editorial board means for authors and institutions.
Internal NIH documents reported by Nature on Aug. 11, 2026 redefine “mission-relevant” stakeholders to exclude policymakers and legislators, putting an estimated 3,700+ FY2025-funded projects with “policy” in the title or abstract at risk and slowing non-competing renewals industry-wide.
NIH held a public webinar on 14 August 2026 to explain its Unified Funding Strategy, the framework in effect since January 2026 that lets Institute directors weigh program balance, geographic balance, and workforce needs alongside peer review scores when deciding which meritorious applications get funded.
ORI’s 2025 Annual Report shows that of 177 misconduct cases closed in 2025, only two ended in a formal ORI finding of research misconduct — 82 closed as decline-to-pursue and 43 as no finding, meaning institutional investigations are doing most of the real work in this system.
The Department of War ordered research security audits at 30 U.S. academic institutions on 17 August 2026, giving them until 31 August to report on foreign collaborations tied to Section 1286 entities and rebranded Confucius Institutes, or risk losing eligibility for future federal research funding.
NSF replaced twelve core disciplinary solicitations with twelve new NOFOs carrying over $1.5 billion, announced 17 August 2026.
The FY 2027 IPPS/LTCH final rule, published 4 August 2026 at 91 FR 49570 and effective 1 October 2026, creates a mandatory nationwide joint replacement bundle (CJR-X) starting 1 January 2028, extends nondiscrimination requirements directly to residency and nursing education programmes under a new 42 CFR 413.84, and reshuffles the quality and Promoting Interoperability measure sets. The operating payment update is 2.3 percent.
FDA issued final versions of three cancer clinical trial eligibility guidances on 27 July 2026, announced in the Federal Register on 28 July. Addressed to industry, IRBs and clinical investigators, they say patients with ECOG PS2 should be included unless a rationale for exclusion is stated in the protocol, that laboratory exclusions must not be carried forward automatically from earlier trials, and that measurable clinical parameters should replace time-based washout periods.
The Education Department published a proposed rewrite of the accrediting agency recognition regulations at 34 CFR part 602 on 20 August 2026 (91 FR 53940). It would remove geographic scope limits, eliminate the two-year rule for new agencies, state that recognition confers no antitrust immunity, require viewpoint-neutral decisions, and impose written-reasoning and appeal requirements on transfer of credit denials. The AIM Committee reached consensus on 21 May 2026. Comments close 21 September 2026; earliest effective date 1 July 2027.
CMS published the RAPID coverage pathway on 11 August 2026 at 91 FR 51710, under which a proposed national coverage determination would issue the same day as FDA market authorisation and be finalised 60 days later for Class II devices and 90 for Class III. The TCET pathway is paused for new candidates from publication. In vitro diagnostics are excluded. Comments close 13 October 2026 under file code CMS-3487-NC.
The CY 2027 Physician Fee Schedule proposed rule, published 16 July 2026 at 91 FR 43842, contains a request for information asking what harms flow from what CMS calls the AMA’s monopoly over CPT-4 licences, what alternatives exist to the CPT and RUC processes, and whether physician procedural services could be paid off ICD-10-PCS instead. A second RFI targets duplicate laboratory and imaging testing. Comments on both close 14 September 2026.
Three OFCCP final rules published on 21 August 2026 rescind the Executive Order 11246 regulations, remove the 7 percent Section 503 disability utilization goal and the CC-305 self-identification form, and update coverage thresholds. The Section 503 and VEVRAA rules take effect 21 September 2026; the E.O. 11246 rescission on 26 October. The VEVRAA hiring benchmark and both affirmative action programme requirements survive.
HRSA published a revised 340B Rebate Model Pilot Program on August 3, 2026, eight months after a Maine district court enjoined the first version and six months after it was vacated. Manufacturer plans were due August 24, 2026, approvals are set for September 24, and the effective date is January 1, 2027. Scope is limited to Medicare-negotiated selected drugs, and HRSA has barred manufacturers from denying rebates over diversion or duplicate-discount concerns.
CMS and the CDC published a request for information on July 16, 2026 asking what should change in the CLIA regulations at 42 CFR part 493, with comments due September 14, 2026. The questions are specific: AI-assisted postanalytic interpretation, remote competency assessment, factory-calibrated analysers, whether data-only facilities need a CLIA certificate, and blood culture contamination monitoring. It is an RFI, not a proposed rule, and CMS has not committed to any rulemaking.
The Department of Energy’s final rule at 2 CFR part 910 subpart C took effect on August 17, 2026, requiring every DOE financial assistance applicant and recipient to hold a written conflict of interest and conflict of commitment policy. Twenty-one commenters, including AAU, COGR and APLU jointly, asked for a one-year lead time; DOE gave thirty days. The 15-day disclosure-update clock is tighter than the PHS standard, and the conflict-of-commitment definition reaches unpaid, honorary and pending appointments.
DOJ’s Data Security Program restricts bulk sensitive-data transfers to countries of concern and reaches university data-sharing and vendor agreements.
PRFB remains open under NSF 26-504 (deadline September 29, 2026), but MPS-Ascend is archived and SPRF (including its Broadening Participation track) is paused pending a new solicitation as of early 2026 — a status check for applicants and research administrators.
NIH’s NOT-OD-26-044 sets FY2026 Kirschstein-NRSA stipend levels for T32 institutional training grants: a flat $29,364 predoctoral rate and tiered postdoctoral rates from $63,480 to $77,076. Tuition/fee allowances are unchanged — here’s what T32 program administrators need to update, and what hasn’t moved.
Full-year FY2026 appropriations for NIH are enacted at $47.5B via P.L. 119-75, ending the earlier CR period. Here’s what that means for award timing, paylines, and NOA processing now.
The 2024 USG DURC-PEPP policy remains the operative framework for institutional biosafety committees even after a May 2025 executive order directed federal agencies to revise or replace it — no superseding text has been issued as of this writing. Here is what IREs, IBCs, and RA offices need in place right now.
JAMA Internal Medicine has declined to retract a 2000 oxycodone-for-osteoarthritis trial despite a co-author briefly backing the request and litigation showing sponsor Purdue Frederick knew of unreported withdrawal symptoms. The journal’s reasoning turns on a narrow standard — fabrication or falsification — that says little about sponsor-level data omission, a gap research-integrity offices should understand.
NIH’s extramural Loan Repayment Program consolidates from six subcategories to three for the FY2027 cycle, opening September 1, 2026. What research administration and postdoc offices should track before applicants start.
REF 2021’s Environment element becomes SPRE in REF 2029, weighted 20% of the quality profile. What UK research offices should gather evidence for now.
Clarivate delisted Cureus from Web of Science in October 2025. What it means for JIF eligibility, researcher CVs, and evaluating mega-journal quality.
Clarivate has restored Web of Science indexing for the Elsevier mega-journal Heliyon, ending a hold placed in September 2024 that followed an internal audit resulting in more than 650 retractions and over 1,000 corrections and expressions of concern.
A Princeton student’s own request led Wiley to retract her PVC-biodegradation paper in May 2026 — a rare, author-initiated retraction. Here’s the practical decision tree for correction vs. retraction vs. expression of concern, why journals and funders treat self-reporting favorably, and how to document it.
Vanier Canada Graduate Scholarships held its final competition in fall 2024 (results April 2025). Canada’s tri-agency funders have folded it into the new Canada Graduate Research Scholarship-Doctoral (CGRS-D) program — here’s what changed and what Canadian research administration offices need to update.
Elsevier has retracted 120+ special-issue articles since June 2026 for systemic peer-review manipulation, with more retractions expected.
A 2025 ORI case summary found that Liping Zhang, PhD, a former Assistant Professor of Nephrology at Baylor College of Medicine, falsified and fabricated western blot and microscopy images across four NIH grant applications (NIDDK, NCI) and three unpublished manuscripts. Zhang did not contest the findings; ORI imposed a two-year debarment and PHS advisory-committee exclusion beginning January 16, 2025.
ORI found Ryan Evanoff, a former WSU scientific assistant, fabricated and falsified DNA sequencing data in NIH-funded research, resulting in a three-year federal debarment.
A Princeton sophomore’s self-initiated retraction of her sole-authored PVC-biodegradation paper, and her follow-up clarification that she did not personally run the described experiments, is a clean real-world case for research offices: a disclosure gap between calculated/modeled results and reported experimental findings, and how CRediT-style contributor-role statements are built to close exactly that gap.
BMJ Public Health retracted Saskia Mostert’s COVID-19 vaccine mortality paper on Aug. 11, 2026, roughly two years after first flagging it — after the paper was cited in a June 2026 Senate hearing while still under an unresolved expression of concern.
NSF deferred the planned PAPPG 26-1 revision and instead published a draft full replacement, the NSF Guidance on Financial Assistance (GFA), for public comment through Aug. 24, 2026. PAPPG 24-1 plus Policy Notices 26-200 and 26-202 remain current policy today.
New agentic leaderboards score AI models on whether they actually finish real tasks, recover from errors, and avoid inventing tools — not on multiple-choice accuracy. For institutions weighing AI agents for literature review, data cleaning, or grant administration, that shift changes what reliable enough to deploy means, and exposes governance gaps in policies built around chatbot use rather than autonomous systems.
Five frontier models now trade the lead by task and price: Opus 5, Fable 5, GPT-5.6, Grok 4.6, Kimi K3. What that means for institutional AI policy.
Frontier-model pricing now spans roughly two to three orders of magnitude. What that spread means for how research offices should structure AI-tool budgets and disclosure policy.
Frontier AI labs are now shipping major model updates within weeks of each other. For institutions with static, named-tool AI-use policies, that pace is becoming a real research-integrity problem: disclosure records that name a specific model version can be functionally unauditable by the time anyone needs to rely on them. Here’s what a review cycle built for this pace actually needs to cover.
Claude Fable 5 now leads LMArena’s Text leaderboard for human-preferred writing, narrowly ahead of Opus 4.6/4.7. For research offices, better AI writing quality doesn’t loosen disclosure obligations — it raises the stakes, since more human-like output means detection tools become a weaker backstop.
Gemini 3.7 Flash is mid-pack on reasoning but the fastest, cheapest model on independent benchmarks. For research-admin screening and triage at scale, that changes the calculus more than the leaderboard rank does.
Claude Opus 5 turns reasoning effort into a per-query dial (low through xhigh/max) rather than a per-model choice, complicating how institutions license, disclose, and govern AI tools.
Intellia’s one-time CRISPR therapy lonvo-z met its primary endpoint in the Phase 3 HAELO trial, cutting hereditary angioedema attacks by 87% versus placebo — a still-investigational result now heading into FDA review.
A gene-burden analysis of 2,811 patients with ataxia, spastic paraplegia, and dystonia identified CD99L2 — previously known only as an immune protein — as a cause of X-linked spastic ataxia, closing a long-standing diagnostic gap.
A Yale-led study reconstructed 832 million base pairs of Denisovan DNA from 177 Near Oceanian genomes, finding evidence of at least three distinct interbreeding events — and thousands of surviving variants still shaping immune response today.
A ten-year clinical trial led by the University of Pittsburgh and University of Chicago found that intracortical microstimulation can safely and durably restore touch sensation in people with spinal cord injury — the longest human study of a brain-computer interface for sensory feedback to date, jointly funded by the NIH BRAIN Initiative and DARPA.
Lipid-laden ‘foamy’ microglia found in progressive MS lesions may drive disease progression, Dutch researchers report in Nature Neuroscience.
A USC rat study in Nature Communications maps a gut-vagus-hippocampus circuit that supports memory after eating, and disrupts under early-life Western diet — work substantially funded by three stacked early-career fellowships (NIA, Quebec FRQS, Alzheimer’s Association) alongside the lab’s NIDDK grants.
Georgetown researchers find that with enough practice, learned tasks shift from the prefrontal cortex to the temporal cortex, letting the brain run two tasks in true parallel rather than rapidly switching between them.
A Penn Medicine study in Neuron finds that GPNMB, an immune-related protein, helps spread Parkinson’s alpha-synuclein pathology between neurons — and that antibodies blocking GPNMB stopped that spread in lab studies. The paper credits specific NIH awards, including R01 NS115139 and P01 AG084497.
A study from the University of Cologne’s CECAD Cluster of Excellence for Aging Research, published in Nature Aging, identifies EPS8 as an aging-linked protein whose rise with age triggers pathological protein aggregation in worm and human cell models of Huntington’s disease and ALS. Reducing EPS8 activity prevented the toxic aggregates and preserved nerve cell function, pointing to a candidate mechanistic link between cellular aging and neurodegenerative disease.
Duke and Rochester researchers used an RNA-editing CRISPR tool to block a shortening event in the SPSB1 gene’s mRNA, restoring MHC-I antigen display on prostate cancer cells and making tumors visible to the immune system in mouse models.
A WashU Medicine study published in Nature finds that mRNA-LNP vaccines prime CD8+ T cells largely through “cross-dressing” — dendritic cells, including cDC2 cells, picking up ready-made peptide-MHC-I complexes from other cells rather than processing antigen themselves. The mouse-model mechanism depends on type I interferon signaling and helps explain how mRNA vaccines generate robust killer T cell immunity.
A Université de Montréal/IRCM team reports in Nature that SLAMF6, a receptor T cells trigger on themselves, acts as a third immune checkpoint distinct from PD-1 and CTLA-4 — a preclinical finding with CIHR funding that could open new combination approaches for checkpoint-inhibitor resistance.
The FDA has approved datopotamab deruxtecan (Datroway) for unresectable or metastatic triple-negative breast cancer, based on the MSK-led TROPION-Breast02 trial, which showed a roughly six-month overall survival benefit over chemotherapy.
MD Anderson has opened a Phase 1 trial of JV-394, a CAR-T therapy targeting CD94, in patients with relapsed or refractory T-cell and NK-cell lymphomas, a cancer type that has long resisted cell-based immunotherapy.
The FDA has approved atezolizumab (Tecentriq) as adjuvant treatment for muscle-invasive bladder cancer, but only for patients whose blood tests ctDNA-positive after surgery — the first approval to use a blood-based biomarker to gate eligibility for a cancer drug.
A Dana-Farber-led study published in Science on July 9, 2026 identifies CARM1, an epigenetic enzyme, as a molecular brake on dendritic cells’ ability to present tumor antigens. Blocking it enhanced how well a cancer neoantigen vaccine primed T cells in preclinical models.
Dana-Farber researchers show CDK8 inhibition slows tumor growth and pushes alveolar rhabdomyosarcoma cells toward normal muscle differentiation.
A Penn-led team built a backpack-portable microbiology lab to run on-site metagenomic sequencing in the Galápagos, tracking multidrug-resistant bacteria in wastewater-contaminated coastal waters without relying on cold-chain sample shipping.
A UVA-led study analyzed 352 probiotic products from major U.S. pharmacy chains and found only 36 unique bacterial species represented, highlighting a gap between commercial formulation and the mechanistic evidence for what each product claims to do.
A University of Vienna (CeMESS) team led by Martin F. Polz and Xiaoqian Annie Yu used a ‘reverse ecology’ approach to show that many gut bacterial species are actually several distinct evolutionary lineages, some linked to aging, IBD, colorectal cancer, and type 2 diabetes.
Researchers at HUN-REN Biological Research Centre, Szeged (Hungary) have identified surface adhesion proteins that act as ‘molecular anchors,’ letting certain gut bacteriophages bind human intestinal cells without infecting them. The finding, published in Nature Communications, points toward more precisely targeted phage therapies and new intracellular delivery strategies.
A 2026 ISME Journal study from Virginia Tech shows bacteriophages that lyse vitamin-B12-producing gut bacteria release the vitamin at levels that reshape surrounding microbial communities — with NIH-funded data deposited in NCBI and Zenodo public repositories.
Two 2025 papers — one using cryo-EM, one using solution NMR — independently worked out how CanA, the building-block protein of the tubular “cannulae” filaments produced by the hyperthermophilic archaeon Pyrodictium abyssi, assembles into hollow fiber networks. The cryo-EM study shows calcium ions alone drive chaperone-free polymerization through a donor-strand-complementation mechanism; the NMR study resolves the monomer’s jellyroll fold and maps its ion-binding sites and polymerization kinetics. Cannulae have been observed since the 1980s connecting Pyrodictium cells into extensive networks, but their biological function is still not established.
Astronomers have confirmed RBH-1, a supermassive black hole speeding through space at 1,000 km/s with a 200,000-light-year trail, as the first directly confirmed runaway black hole — and a separate study now traces its likely origin to a gravitational-wave recoil kick from an earlier black-hole merger.
A multi-observatory team using JWST, Hubble, the VLT, Chandra, ALMA and the VLA has caught a distant red quasar — nicknamed ‘the Hatchling’ — in a rarely observed transition phase, as outflowing gas and dust clear away from its active nucleus.
Euclid has identified 31 quasars in the early Universe, including two record-breakers from when the cosmos was just 670 million years old — and the catalogue behind the find is going into the public record for other researchers to use.
LVK’s GWTC-5.0 catalog adds 161 new detections for 390 total gravitational-wave events since 2015 — all released as open data via GWOSC, and a live case study in authorship credit at collaboration scale.
A Georgia Institute of Technology study in Ecotoxicology and Environmental Safety finds that sulfoxaflor, a widely used systemic insecticide, shifts gene expression in bumblebee ovarian tissue at doses below levels expected to cause visible harm, raising questions for pesticide risk assessment.
A USDA-led team used transposable-element ‘molecular clocks’ to trace the cultivated strawberry’s octoploid genome to three ancient hybridization events, revealing four ancestral subgenomes and a new method for studying polyploid crops.
A China Agricultural University study published in Microbiology Research finds that salt-stressed maize roots release extra arginine, recruiting Pseudomonas bacteria that switch on a NAC-family gene and boost lignin production in root cell walls, reducing sodium uptake and pointing toward microbiome-based approaches to salt-tolerant crops.
A shelf audit of 2,783 toddler-food products across 21 Austin, TX grocery stores found 81% were ultra-processed under the Nova classification system and 49% failed at least one WHO nutrient benchmark. Presented as a conference abstract at NUTRITION 2026 — not yet peer-reviewed.
Bees exposed to a sublethal glyphosate dose foraged 13% less within three days and showed altered brain chemistry, a Virginia Tech-led study in the Journal of Experimental Biology finds.
Baylor College of Medicine researchers recorded individual hippocampal neurons in epilepsy-surgery patients under general anesthesia and found the brain still distinguishes nouns, verbs, and adjectives, and even predicts upcoming words — evidence of structured language processing without consciousness. Because the data can only be collected while the patient is unconscious, all consent has to be obtained pre-operatively, a genuinely distinct human-subjects-ethics scenario from research where a participant can object in real time.
Researchers at IMT Lucca applied natural language processing to more than 3,700 dream and waking-experience descriptions from 287 participants, finding dream content reflects a mix of personality traits and environmental context — including a detectable COVID-19 lockdown signature — rather than literal replay of daily events. The 3,700-report corpus itself raises genuine research-data-management questions: de-identifying deeply personal diary text, repository deposit, and reuse licensing.
A two-year Binghamton University study tracking 242 children’s eye movements toward emotional faces found a measurable attention marker linked to depression risk — one that shifts differently depending on whether a child’s mother has a history of major depressive disorder. Because the study collects family mental-health-history data on minors and assesses inherited depression risk, it required heightened IRB review and parental consent, a genuine human-subjects-ethics angle.
A small University of Bristol-led pilot trial found the anti-inflammatory drug tocilizumab produced 54% remission in treatment-resistant depression versus 31% on placebo (NNT=5) over four weeks. The 30-person trial, funded by Wellcome, NIHR, and the BMA Foundation, is explicitly framed by its own authors as proof-of-concept requiring a larger confirmatory trial — and repurposes an approved rheumatoid-arthritis biologic off-label for a psychiatric indication, a genuine human-subjects-ethics angle.
In a Charité-led, double-blind, placebo-controlled trial of 170+ PTSD patients, the THC medication Dronabinol cut nightmare severity nearly twice as much as placebo over ten weeks, and more than a third of treated patients stopped having nightmares entirely. The trial was funded by Bionorica SE, a pharmaceutical manufacturer with a commercial stake in THC-based products — a genuine conflict-of-interest disclosure story — and its at-home, self-administered dosing design in a trauma-exposed population raises real research-ethics protocol questions.
A white paper from 135 researchers across eight Horizon Europe-funded consortia warns that fragmented EU policy — not just pesticides — is a major barrier to reversing wild-pollinator decline, and sets out 15 recommendations to inform the European Commission’s Pollinators Initiative.
A Nature Communications study confirms Saxifraga candelabrum traps, digests, and absorbs nutrients from insects — meeting all four formal criteria for carnivory and validating a hypothesis Charles Darwin first proposed in 1875 but could not prove.
A Denmark-Austria research team describing a new rove beetle genus from China’s Yunnan Province and northern Laos named it Luffy, after the elastic-limbed One Piece protagonist. The ZooKeys paper, like nearly all modern taxonomic description, publishes open access under CC BY 4.0.
A six-year DNA barcoding partnership between Ecuador’s Inabio and the University of Guelph’s Centre for Biodiversity Genomics identified 8,057 candidate insect and arachnid species at the Mashpi-Tayra reserve, 97% of them locally endemic — a demonstration of what shared genomic reference infrastructure can do at scale.
Syilx-Okanagan, Secwepemc and Ktunaxa nations are running the tagging and hatchery science behind a binational push to return salmon above Grand Coulee Dam, paired with a US$200M US federal commitment to Upper Columbia United Tribes — a case study in cross-border Indigenous-led conservation research.
The CMS COP15 Global Assessment of Migratory Freshwater Fishes (released March 2026) found an 81% decline in migratory freshwater fish populations since 1970, with 325 species flagged as international protection candidates. The finding drove a ten-year, cross-border Multi-species Action Plan for Amazonian Migratory Catfish — a case study in the data standardization and international cooperation that large-scale conservation and research both depend on.
Researchers CT- and micro-CT-scanned a rare 1966 vaquita skeleton and uploaded the 3D models to MorphoSource, an open-access repository, creating a permanent, freely accessible anatomical record of the world’s most endangered marine mammal.
India’s tiger population has more than doubled since the low point of the 1970s, from roughly 1,827 animals in 1972 to 3,682 in the 2022 census, and the country now holds an estimated three-quarters of the world’s wild tigers. But conservation researchers say the next phase of recovery depends less on reserves themselves than on the corridors connecting them — and those corridors are under mounting pressure from roads, mining, and encroachment.
A new ZooKeys study led by Manfredo A. Turcios-Casco and an international team spent eight years reconciling over 300,000 museum, field, and publication records to confirm 227 native mammal species in Honduras — and to expose where modern distribution data still doesn’t exist.
A comprehensive taxonomic revision combining museum DNA, field surveys and frog calls has added seven new diamond frog (Rhombophryne) species to Madagascar’s amphibian fauna, bringing the genus to 27 species. The Denmark-Germany-Madagascar research team’s findings are already informing the country’s Biodiversity 30×30 protected-area planning.
Argonne National Laboratory and the University of Illinois Chicago built a multi-agent AI framework that plans, runs, and validates atomistic and molecular-dynamics simulations end to end from a single natural-language prompt — distinct from earlier AI screening tools because it automates the simulation pipeline itself. The paper names two DOE Office of Science user facilities in its affiliations, Argonne’s Center for Nanoscale Materials and its Leadership Computing Facility, and the full framework code is public on GitHub under an MIT license.
ergoCub is a new humanoid robot whose hardware and control software were optimized together around human ergonomics, reducing measured lower-back strain for people lifting alongside it. It was developed through a three-way collaboration between the Italian Institute of Technology (IIT), the University of Manchester, and industry partner GenerativeBionics, described in a new Nature Machine Intelligence paper; specific funding for the study could not be independently confirmed.
MIT researchers and international collaborators have published FloatForm, a fleet of small robotic boats that self-assemble into bridges, platforms, and other floating structures on command, in the open-access journal Nature Communications. The work traces back to the MIT-AMS Institute Roboat collaboration in Amsterdam, illustrating a multi-year, multi-country research lineage published openly from the outset.
KAIST researchers have built APT-RL, a control system that lets their HOUND quadruped robot choose its own gait — trotting or bounding — in real time across stairs, slopes, and forest terrain, reaching peak speeds of about 6 m/s. The paper’s author list, published by KAIST in Science Robotics, names both Korea University and South Korea’s Agency for Defense Development as co-author affiliations — an explicit funder/affiliation transparency case study for research-administration readers tracking dual-use disclosure.
An MIT-led team has built a bird-like robot that flies straight out of the water without paddling first, detailed in a July 2026 Science paper. Beyond the engineering, the author list itself is notable: co-authors from MIT, EPFL (Switzerland), and Northwest Indian College — a US tribal college — with field trials carried out at Lake Geneva.
Google DeepMind’s Gemini Robotics 2 gives humanoid robots coordinated whole-body control, but the notable part for research administrators is what shipped alongside it: a dedicated Safety Technical Report and a new ASIMOV-Agentic benchmark testing whether the AI will refuse unsafe commands and escalate to a human when uncertain. DeepMind also validated the system across independently-made hardware, including Apptronik’s Apollo 2, Franka Duo, and platforms from Dexmate, SO101, and Trossen, alongside partners Boston Dynamics and Agile Robots.
Google DeepMind’s WeatherNext Cyclones model now produces three-day storm forecasts as accurate as prior two-day forecasts, a gain validated in a peer-reviewed Nature paper, released as open-source code and weights on GitHub, built with NOAA’s National Hurricane Center, the UK Met Office and CIRA/Colorado State University, and trained on the shared IBTrACS storm-track archive. It was used operationally by the National Hurricane Center during Hurricane Melissa in the 2025 season.
ESA has uplinked a major software update to its Hera spacecraft, transmitted across roughly 140 million kilometres of deep space, activating the instruments and autonomous-navigation systems Hera needs to approach the asteroid moonlet Dimorphos when it arrives this autumn — the follow-up survey to NASA’s DART kinetic-impact test.
NASA engineers have extended Voyager 2’s science mission by at least a year through a power-conservation effort nicknamed the “Big Bang,” swapping in lower-power alternatives to keep its three remaining instruments running as the spacecraft’s plutonium-fueled RTG steadily loses power nearly 50 years after launch.
JPL has tested a lightweight radar antenna for SkyFall, a proposed 3-helicopter Mars mission concept to map subsurface water ice. The antenna survived 200 simulated landings ahead of a possible late-2028 launch — engineering validation, not a discovery; SkyFall remains an unfunded concept.
Juno’s microwave radiometer has taken the first subsurface heat-flow readings on Io, finding background heat release up to 30x Earth’s average — and offering a clean example of NASA’s competed, PI-led New Frontiers funding model at work.
NASA’s Psyche spacecraft used a May 2026 Mars gravity-assist flyby to test its imager, magnetometer, and spectrometer, producing a time-lapse video and calibration data cross-checked against NASA, ESA, and UAE Mars missions ahead of its 2029 asteroid arrival.
On July 2, 2026, NASA’s Perseverance rover captured the first-ever observation from another planet’s surface of Earth vanishing behind a moon — Mars’s moon Phobos — using its Mastcam-Z instrument, a three-institution collaboration between Arizona State University, Malin Space Science Systems, and JPL.
NASA’s Curiosity rover has imaged a field of honeycomb-shaped polygonal fractures in Mars’s Valle Grande. The cause, mud cracks, thermal cycling, or compression, is still undetermined, and the underlying mission data will eventually be archived in NASA’s public Planetary Data System.
An 18-year University of Calgary study found CWD prions produced a faint, assay-detected signal in 2 of 18 macaques. Experts genuinely disagree on what that means for human risk — here is the real range of opinion, not a flattened verdict.
An oral antiviral, GHP-88310, blocked both airborne and contact spread of a measles-like virus in a Georgia State University ferret study — a preclinical step toward outbreak-response tools amid the global measles resurgence.
Swiss researchers identified a new Simbu-serogroup orthobunyavirus, spread by midges, behind a milk-drop illness in cattle herds. It is not classified as a regulated disease and is not considered zoonotic.
HZDR researchers in Dresden report two lab-scale methods — hydrodynamic cavitation and cold atmospheric plasma — that break down PFAS ‘forever chemicals’ by attacking the carbon-fluorine bond directly, rather than just filtering it out of water.
University of Illinois Urbana-Champaign researchers screened 141 CRISPR base editor variants and identified one that disrupts a splice site in the huntingtin gene, triggering exon skipping that produces a proteolysis-resistant protein. In rodents, the approach reduced toxic HTT fragment formation, aggregation, and brain atrophy — a preclinical, in vivo finding published July 29, 2026 in Nature Biomedical Engineering, with an earlier preprint version posted on bioRxiv in 2024.
Rockefeller University’s Jarvis lab has produced the first fully phased, diploid, telomere-to-telomere genome of a songbird, recovering 2,710 genes missing from the zebra finch reference genome researchers have relied on since 2010.
Researchers at Peking University used DeepMind’s AlphaFold3 to map which structural contacts distinguish CRISPR-Cas9’s on-target and off-target binding, then redesigned the enzyme around that map — cutting measured off-target activity from 28% to 5% and pointing gene-editing safety work toward mechanism, not just cataloguing.
A six-institution, NIH-funded US-German consortium led by UC Santa Cruz has produced the first telomere-to-telomere marmoset genome, a gap-free reference that surfaces 76 candidate genes for Alzheimer’s and Parkinson’s research, including new variation in PSEN1, and is released as an open resource for the whole research community.
Stanford researchers used the Evo genome-language model to design 16 functional synthetic bacteriophages from scratch, and biosecurity specialists warn the AI-generated genomes evade existing DNA-synthesis screening tools built on known-pathogen databases.
A Beijing-led team engineered a ruthenium-ceria nanocatalyst that converts a lignin-derived quinone into 1,4-cyclohexanediol, a plastics and resins building block, at 96.7% yield using only water as the solvent, no organic solvent required.
All four LHC experiments — ALICE, ATLAS, CMS and LHCb — independently found signatures consistent with quark-gluon plasma in oxygen and neon collisions and reported it jointly, a rare instance of four separately governed, multi-thousand-author collaborations coordinating a shared result.
New York’s first confirmed Bourbon virus case, on Long Island, spotlights a rare tick-borne virus with no vaccine, no treatment, and no standard clinical test — and the diagnostic-funding gap behind chronic underdetection.
ATLAS’s April 2026 result sets record-tight limits on the Higgs boson’s self-coupling, the last untested piece of the Higgs mechanism. The paper’s byline: over 5,500 collaboration members — a real test case for crediting authorship at scale.
A new in-cell protein contact map shows influenza A virus dismantling paraspeckles — nuclear structures normally used for gene regulation — to release host factors that boost its own replication, per a July 2026 Nature Microbiology study.
A Kobe University-led seismic survey with JAMSTEC has found direct evidence that Japan’s Kikai caldera is actively refilling with magma, 7,300 years after one of the largest eruptions of the last 10,000 years. Researchers stress no eruption is imminent — but the finding, made possible by shared seismic and geophysical datasets across institutions, underscores why open hazard-monitoring infrastructure matters.
HD Hyundai Heavy Industries has completed the ninth and final ITER vacuum vessel sector, closing out a manufacturing effort split across South Korea and the EU’s procurement shares. The milestone highlights how ITER’s seven-member treaty structure (EU, US, Japan, China, Russia, India, South Korea) governs technology transfer, IP, and export control across members with sharply different bilateral trade-control relationships.
SYNCHRONY, a 27-institution, EU-funded project coordinated by the Alfred Wegener Institute, is building a unified observing system to consolidate the Southern Ocean’s scattered climate data streams — with five UK institutions and Asia’s sole participant, the Korea Polar Research Institute, on board.
Zoological Survey of India researchers have described Apristurus drona, a new deep-sea catshark with striking white eyes, discovered off Kerala’s coast and confirmed through combined DNA barcoding and morphological analysis under India’s Deep Ocean Mission.
Researchers have mapped every neuron and connection across a fruit fly’s brain and ventral nerve cord, finding that behavioral control is distributed across circuits throughout the whole nervous system rather than issued from a single command center. The full connectome, called BANC, is now free and publicly browsable via the FlyWire Codex.
Sediment cores from two international ocean-drilling programs show that 3.4 million years ago the Indian Ocean’s ‘Agulhas Leakage’ nearly shut off while the Atlantic’s overturning circulation intensified instead of weakening, upending a textbook assumption about how the two systems are linked.
A Stanford-led Nature study finds that blood stem cells send immune cell reinforcements into the aging human brain, forming microglia-like cells in a process traced through shared DNA mutations — a phenomenon not seen in mice or nonhuman primates, and one that upends the long-held idea of the brain as immune-privileged.
A Shanghai Astronomical Observatory-led team used dual-frequency Event Horizon Telescope data to produce the first spatially resolved map of how M87’s black hole glow changes near the event horizon.
A UC San Diego postdoc discovered a hidden giant planet, Beta Pictoris d, buried in James Webb Space Telescope spectroscopy data from inside one of the sky’s brightest debris disks.
A Chinese satellite’s X-ray trigger set off a rapid global observing campaign that caught only the second confirmed X-ray shock breakout ever recorded, from supernova SN 2026gzf.
UC Irvine astronomers confirmed a new super-Earth, GJ 3378b, sitting in its star’s habitable zone — verifying the signal independently with two separate spectrographs, HPF and NEID.
University of Minnesota researchers built SpudCell, a synthetic cell assembled entirely from nonliving chemistry, with a 90kb genome that grows, divides, and evolves through Darwinian selection — with no living-cell scaffolding. The team also launched Biotic, a nonprofit to keep the underlying methods openly shared.
An Aalto University-led consortium used machine-learning pre-screening plus first-principles calculations to predict two new kagome superconductors, YRu3B2 and LuRu3B2, later confirmed in the lab — a proof of concept for AI-accelerated materials discovery, published in Physical Review Research.
Researchers at Cold Spring Harbor Laboratory and Scripps Research have identified a small molecule, pghi-4, that blocks a bacterial enzyme called SagA and restores the antibiotic vancomycin’s ability to kill vancomycin-resistant Enterococcus faecium, a drug-resistant ‘superbug.’ The work, published in Nature Communications, was supported by six funders including the NIH and the Australian Research Council.
Geneticists analyzing living human genomes — no fossils involved — have identified two previously unknown archaic hominin lineages: a ‘ghost’ population that interbred with humans over 50,000 years ago, and an even older lineage detected only through its trace in Denisovan DNA. The find rests entirely on open, reusable genomic reference data.
More than 100 fossils from a 567-million-year-old site in Canada’s Northwest Territories, including Dickinsonia, Kimberella and Funisia, push back key milestones in early animal evolution by 5 to 10 million years. The find, led by AMNH’s Scott Evans with Stanford, Penn State and Dartmouth, was funded by a NASA Exobiology grant and three NSF earth-science awards.
MIT, TU Munich, and University of Antwerp researchers have identified why solid-state batteries often fail: electrical imbalances at the grain boundaries inside the solid electrolyte trigger the lithium dendrite growth that short-circuits the cell. Adjusting how the electrolyte is processed cut that imbalance and raised the critical current density by over 300%.
SaxonQ, a Leipzig startup, has opened orders for room-temperature diamond NV-center quantum computers that need no dilution refrigerator — a hardware shift with implications beyond the lab.
A 1.43-million-year-old trackway of 21 footprints at Kenya’s Lake Turkana shows some Paranthropus boisei individuals stood up to 1.8 meters tall and appear to have moved together as a group — new evidence, from a US-Kenya research collaboration, that reshapes how large and how social this early hominin species really was.
Researchers at Eurac Research’s Institute for Mummy Studies have sequenced a still-living community of cold-adapted yeasts and ancient gut bacteria on the 5,300-year-old Iceman mummy — some of which appear to feed on phenol, a chemical once used in the specimen’s own conservation.
Fossil vertebrae from the giant shark Otodus megalodon, long believed destroyed in a 1989 museum transfer, have been rediscovered on a shelf at a Danish museum. Re-analysis of the specimens, published in Palaeontologia Electronica, confirms the species could exceed 24 meters (79 feet) in length.
A room-temperature levitated-magnet sensor reaches SQUID-level sensitivity (32 femtoteslas per root-hertz) without cryogenics or magnetic shielding, closing the sample-to-sensor gap to a few hundred micrometres. It is a physics proof-of-concept, not yet a working MEG scanner.
A generative AI system called Raygun, described in Nature on 29 July 2026, can shrink, expand and edit natural proteins while aiming to preserve their fold and functional sites — reframing protein length as a designable variable rather than a fixed constraint, and sharpening a validation bottleneck that already outpaces wet-lab screening capacity.
Nature study assembles 2,110 human centromeres across 28 populations, finds 226 haplotypes — and shows standard genomic tools can’t read them.
Two variola virus genomes recovered from 500-year-old Chilean mummies expand known sequence diversity for a select agent through archaeological DNA recovery, not live-virus handling — an edge case dual-use oversight was not written to cover.
A Bundibugyo ebolavirus outbreak (PHEIC since 17 May 2026) has no disease-specific licensed vaccine. WHO is deploying the Zaire-strain Ervebo against it via a Phase 3 trial on cross-protection evidence, skipping Phase 2 — a trial-only, not compassionate-use, response.
A Nature paper says IXPE X-ray polarization data from a magnetar shows vacuum birefringence. A separate, earlier peer-reviewed analysis of the identical dataset says the same signal is not compelling evidence for it. Both are right about what the instrument saw — they disagree on the geometric model used to interpret it.
FDA granted accelerated approval to Tudriqev (RP1) plus nivolumab for advanced melanoma on Aug 6, 2026 — after two Complete Response Letters on the same IGNYTE single-arm trial. Here is what changed in the evidence review, and what the required confirmatory trial still has to show.
UKRI’s MRC has reopened its paused translational funding routes under new names: Proof of Concept (was DPFS) closes 18 Nov 2026, Impact Acceleration Award (was Gap Fund) closes 11 Nov 2026 and funds £50k-£300k. What UK research offices should do now.
California’s SB 942 AI Transparency Act took effect August 2, 2026 — not the January 1, 2026 date still cited across much of the web — after AB 853 delayed it to align with the EU AI Act. It requires large generative-AI providers to offer free AI-content detection tools plus visible and embedded watermarking, with implications for journal and institutional AI-disclosure policy.
UKRI/STFC will end e-MERLIN funding after March 2028, putting Jodrell Bank’s Lovell Telescope at risk. What the cuts mean for UK research partnerships.
Japan’s EU-Japan Horizon Europe association agreement took effect 30 July 2026, making it the 23rd associated country and the most populous. Here’s what changes for proposal eligibility, consortium coordination, and EU-Japan funding partnerships.
The USG Policy for Stopping High-Risk Life Sciences Research (July 2026) replaces the 2024 DURC/PEPP framework with new DGOF and IROC rules, institutional certification and monitoring duties, and a 120-day agency guidance deadline.
DOE selected 278 AI-for-science projects across 342 institutions in the first Genesis Mission funding round announced July 22, 2026, led by a $60M nuclear-AI award and multi-project wins for Oak Ridge, Stanford/SLAC, MIT and Iowa State. Here’s who won, how the funding mechanism works, and how it differs from NSF’s parallel AI-hubs program.
Fields Medalist Jacob Tsimerman’s move from a University of Toronto professorship to OpenAI’s AI-safety team, announced hours after his July 2026 award, is a concrete signal that frontier AI labs can now recruit at the very top of pure mathematics — and that proof-grade verification rigor is becoming a recruited AI-safety specialty.
NIH Director Bhattacharya personally signed an Aug. 4, 2026 letter terminating a Pitt health-disparities grant, following a July Emory cut. What the letter-vs-notice difference means for appeals.
A Prothom Alo investigation counted 325 papers linked to Bangladeshi institutions retracted between 2019 and June 2026 — plus named researchers with double-digit counts, a former vice-chancellor’s paper-mill retractions, and AI-generated content findings at Islamic University, Kushtia.
STAT News reported on August 5, 2026 that a child enrolled in a HuidaGene Therapeutics CRISPR trial for Duchenne muscular dystrophy died of ARDS during a severe immune reaction roughly a year before the death was disclosed — a second undisclosed pediatric death in a Chinese gene-editing trial to surface within weeks, this one run under China’s investigator-initiated trial pathway with no independent safety monitoring board.
China’s MOFCOM added a Polish university to its dual-use export control list — a first for EU higher education. What it restricts and why it matters.
A 1,154-patient IMPACC cohort study found anellovirus reactivation, not EBV, tracks long-term disability in long COVID — and revises what EBV reactivation actually signals.
The 2026 domestic cyclosporiasis outbreak is CDC’s largest on record. The specialist angle: why routine ova-and-parasite exams miss Cyclospora cayetanensis, and the modified acid-fast staining, UV autofluorescence, and PCR methods that actually confirm it.
On August 5, 2026 the FDA approved Takeda’s oveporexton (Orzeyful), the first orexin receptor agonist for narcolepsy type 1, based on two Phase 3 trials (FirstLight, RadiantLight). DEA scheduling review and commercial availability are still pending.
UUP members ratified a new five-year SUNY contract on July 27, 2026 with nearly 98% approval — one of the highest margins in the union’s history. The deal (July 2026-July 2031) includes annual raises, new retention awards, and AI-accountability language requiring SUNY courses stay under human direction, with implications for research-office budgeting and AI policy.
Brown University President Christina H. Paxson announced on August 3, 2026 that she will step down at the end of the 2026-27 academic year, ending a 15-year tenure. Chancellor Brian T. Moynihan confirmed the Corporation will launch a national search for her successor, with the transition effective June 30, 2027.
AAUP and the ACLU of Texas sued the Texas A&M University System in early August 2026 over a policy restricting faculty teaching on race, gender, and sexual orientation, arguing it is unconstitutionally vague and violates the First Amendment. The case tests how much authority a governing system has over classroom content versus faculty academic freedom.
Fabricated Op4G/Slice MR survey data reached NIH-funded studies at Northwestern, UNC and U Chicago. One retraction is in; here is what PIs should do.
Illinois Institute of Technology cut 160 jobs at the end of July 2026, citing both research-funding losses and lost international enrollment (down ~1,200 international graduate students). The same week brought further cuts at Harvard ($365M FAS deficit), Temple, Saint Louis University, LSU, and others — and downward revisions to two previously reported figures at Southern Oregon and Portland State.
A 2026 Science and Justice paper argues dry labbing, reporting results for tests never run, is fabrication, not falsification, and deserves its own category.
Clarivate will close Research Professional News on 31 December 2026. Founder William Cullerne Bown, who launched it in 1994, plans a successor.
A July 2026 arXiv study tests five hallucinated-citation checkers and finds none reliable enough to run unsupervised. What each tool gets right, and wrong.
Sage issued an Expression of Concern on a 2021 Journal of Humanistic Psychology paper on 12 March 2026, more than a year after a retraction request. As of August 2026 no final decision has been announced, illustrating how long an EoC can remain open under COPE’s guidance.
Karnataka’s Collegiate Education Department has ordered criminal cases and permanent blacklisting for 249 guest lecturers after universities confirmed the PhD certificates they submitted to secure government college appointments were fake or invalid — a case that turns on when credential verification happens in the hiring sequence.
Police removed 5 researchers from ADA’s June meeting over a Diabetes Care editorial. 200+ members now demand resignations and editorial independence.
China banned an unproven Alzheimer’s neck surgery and detained its inventor in 2025. Registered trials of the same procedure continue abroad.
OpenAlex fixed 6,191 mismatched affiliations across 192 watch-listed orgs, exposing a data-quality risk in research-security screening.
NSF and UIDP launched a $47M, five-year pilot funding a four-year PhD model that guarantees at least one year of industry-embedded dissertation research, split-funded by university, NSF, and a required $100k+ industry contribution per student. First cohort: fall 2026.
Circadian biologist Satchidananda Panda will leave the Salk Institute for Biological Studies on 13 August 2026, ending a 22-year tenure, after an independent investigation into sexual misconduct allegations. Panda denies the allegations; Salk has not released the investigation’s findings.
Kaggle removed a flawed stroke-detection dataset in July 2026 after a copyright complaint — five months after a research-integrity complaint about the same data went nowhere. Three Scientific Reports papers built on it have now been retracted.
The paper claimed 229 countries of data; its cited source lists at most 143 in any year of the study window. The journal’s investigation remains open.
On August 3, 2026, Education Secretary Linda McMahon asked every university president and governing board to publish, by year-end, a public statement across seven areas — including safeguarding research from foreign influence and prioritizing American interests. There is no funding condition and no enforcement mechanism. Here is what the two research-facing asks actually mean for research offices, and how the letter differs from the failed 2025 Compact for Academic Excellence.
HHS Secretary Kennedy has given Sage Open Medicine until Aug. 15, 2026 to justify a May expression of concern, citing COPE notice-transparency rules. Verified timeline and open questions.
The Senate passed its continuing resolution 90-6 on August 8, 2026, including a provision blocking OMB’s grant-rule rewrite through December 11 — but the House already passed a different CR without that provision, and the two remain unreconciled.
Of 30 papers flagged on PubPeer, four by Reyhan Polat and one by Julide Ergil are now retracted. ESAIC is due to report on its Ergil review by 31 August 2026.
NSF 26-513 opens $100M for up to 10 State and Regional AI Infrastructure Hubs (Nov. 4 deadline). NSF funds coordination and training; consortium partners must fund the compute itself. Here is who can lead, what is required, and the eligibility rules that matter most.
Freie Universität Berlin has awarded its 2026 Rosalind Franklin Prize to Anna Abalkina, co-creator of the Retraction Watch Hijacked Journal Checker.
A July 2026 SSRN preprint by KAIST researcher Hana Kim finds 401 granted US patents cite retracted scientific papers, and that an audit of a high-impact subset found substantial reliance on the retracted findings in some cases. The paper has not been peer reviewed; here is what it actually found and what it did not.
Shanghai Jiao Tong University has opened a formal investigation, and Nature has posted an editor’s note, after Science and Retraction Watch reported that a 6-year-old girl died days after an experimental base-editing gene therapy overseen by neuroscientist Zilong Qiu — a death, along with the family’s roughly $860,000 contribution to the therapy’s development, that was not disclosed in the resulting Nature paper.
A federal whistleblower suit alleges 4 publishers overcharged APCs on federally funded papers; DOJ declined to intervene. Allegations, not findings.
Jason Arday resigned his Cambridge professorship and Jesus College fellowship on 5 August 2026 as the university opened a new inquiry into his qualifications and honorary appointments, alongside a separate academic-misconduct review already underway.
Research Square withdrew three preprints tied to a Nepal-run, 1,000-member research network; ESMO and AHA are now reviewing further submissions.
aiXiv is a new preprint platform, reportedly linked to researchers at the University of Toronto, Oxford, and Tsinghua, that accepts AI-written papers and reviews them using multiple LLM agents instead of human referees. It is a direct counterpoint to arXiv’s recent moves to restrict unchecked AI content — and a new BadScientist study shows LLM reviewers can be fooled by convincing-but-unsound fabricated papers, raising real questions for how research administrators and librarians should treat its output.
COPE’s current retraction guidelines, revised in 2025, explicitly list undisclosed AI-generated content and third-party/paper-mill authorship as grounds for retraction alongside the established criteria. Here is what changed, what stayed the same, and what it means for editors and research-integrity officers.
The EU’s Digital Omnibus (Regulation (EU) 2026/1744) formally entered into force on 27 July 2026, deferring key AI Act high-risk deadlines to December 2027 and August 2028. It does not delay everything — here’s what changed, what didn’t, and what research organizations should do now.
Carnegie Mellon’s Swartz Center for Entrepreneurship launched a Deep Tech Venture-Ready Program in April 2026 backed by $240M in soft-circled capital from 30 VC and corporate partners — a distinct model from a university venture fund, worth understanding precisely because the capital is prospective, not committed.
FDA’s July 2026 Unified Agenda lists a dozen new proposed rules on clinical trials, Phase 1 IND, DTC ads, and CRL disclosure beyond the IND pilot.
HHS OIG is asking whether the Anti-Kickback Statute needs a new safe harbor for paying clinical trial participants. Comments on the RFI are due August 24, 2026.
Advances in Psychology has paid $100/review since 2022; NIH may reward journals that pay reviewers ~$50/hr and publish their comments.
A 2026 Scientometrics analysis of 248 CoARA action plans finds aspirational ‘values’ language far outweighs concrete operational commitments to open science.
DORA, FORCE11, CoARA and ALLEA convened funders, publishers and universities in Singapore to compare Asia-Pacific approaches to research-assessment reform.
Chile’s ANID is extending its 2022 Open Access Policy across every instrument it funds in 2026, backed by a new EspacioCiencia repository service and renewed InES Ciencia Abierta capacity funding. Here’s what the mandate actually requires.
In May 2026, DORA, the Global Research Council’s Responsible Research Assessment Working Group, and Science Europe jointly published a practical implementation guide for research funding organizations moving toward responsible research assessment — the first RRA resource written specifically for funders rather than institutions.
The UPC’s Patent Mediation and Arbitration Centre opened in phases from May 12, 2026 — what it means for university patent-licensing and enforcement strategy.
FDA shipped Elsa 4.0 and the HALO data platform in May 2026 — an internal AI upgrade, not a sponsor-facing one. Here is what changed and what did not.
EMA’s draft guidance on running clinical trials during public health emergencies closed for comment April 30, 2026. Finalisation is still pending.
FDA’s April 2026 RFI sought input on an AI-enabled early-phase trials pilot. Comment window closed June 29, 2026 — here’s what it covered.
A BMJ study used a BERT classifier to screen 2.6 million cancer papers, flagging 9.9% as suspected paper-mill output — a scale manual review cannot match.
The European Commission’s June 2026 study analysed 263 ARRA action plans, finding reform engagement broad and growing but uneven across Europe.
Clarivate paused Web of Science indexing for six IJS Publishing Group journals after mandatory reporting-guideline citations inflated their impact factor.
Nature reports China’s multiple-corresponding-author rate hit ~30% by 2020, up from 21.6% in 2016 — tied to evaluation incentives, not byline convention.
A 2026 Journal of Informetrics study uses CRediT data to measure contribution among co-corresponding authors, finding it rises with byline position.
A January 2026 Royal Society Open Science paper models why contribution-insensitive authorship norms (alphabetical, senior-last) evolve via a ‘Red King’ dynamic — and shows they measurably discourage collaboration compared to contribution-sensitive norms.
EO 14332 (Aug. 7, 2025) directs new termination-for-convenience rights, F&A-cost preferences, and DEI-linked terms for discretionary federal grants.
The Royal Academy of Engineering’s 2026 Spotlight on Spinouts report finds UK universities’ average spinout equity stake has fallen to 16%, a decade low, down from 22% the year before — with life sciences averaging 20% and hardware 14%, both within the Independent Review’s recommended 10-25% band.
NIH plans to widen All of Us pediatric enrollment to ages 0-12 in 2026, even as the program absorbs a steep funding drop from FY2023 levels.
FDA eased CMC expectations for cell and gene therapy BLAs on Jan 11, 2026 — finalized in May, extended to genome editing in June.
New Zealand has cancelled PBRF quality evaluation for good; Australia’s ERA replacement remains undesigned three years after ERA ended in 2023.
NSF’s own FY2027 budget request confirms its Office of Inspector General has cut roughly 22 positions (24%) since January 2025, lost its investigative-scientist staff, and now refers research-misconduct allegations to grantee institutions instead of investigating them directly — following the departures of Inspector General Allison Lerner and Deputy IG Ken Chason.
A Lancet Correspondence auditing 2.5 million PubMed Central papers found fabricated citations rose from 1-in-2,828 papers in 2023 to 1-in-277 in early 2026 — and over 98% of flagged papers have seen no publisher correction.
RDA’s 27th Plenary meets in London Oct 6-8, 2026, hosted by UKRI — piloting a new cadence pairing yearly virtual and in-person meetings.
The EU’s proposed Biotech Act (Commission proposal adopted 16 December 2025, not yet enacted) would revise Clinical Trials Regulation Article 93 to align it with GDPR, naming sponsors and investigators as data controllers and permitting cross-trial data reuse — here is what is actually proposed, what the EDPB-EDPS flagged as unresolved, and what remains to be decided.
NeurIPS 2026 has made the Machine Learning Reproducibility Challenge an official track, with TMLR-accepted papers presented in Sydney this December.
OpenAlex’s January 2026 roadmap: the Walden rewrite to Databricks is done, Awards is now a first-class entity, and credit-based API pricing is rolling out.
Kenya launched a 2026-2036 research-financing masterplan and the Grand Challenges Kenya fund to close its R&D spending gap and cut aid reliance.
An FDA warning letter dated July 10, 2026, cites a bioequivalence-trial investigator tied to an Alembic Pharmaceuticals facility for obtaining informed consent after study procedures had already begun. Here is what the letter actually says, and what unverified secondary claims about it do not hold up.
RoRI’s PEER REVIEW project wraps up with a June 2026 report: peer review has hit a breaking point, and needs a layered, funder-led reform blueprint.
As of Feb. 2026, OpenAlex requires an API key for all production API use and bills most calls on usage, with a daily free allowance per key.
A June 2026 House Science subcommittee hearing examined FCA grant-fraud enforcement, spotlighting undisclosed foreign affiliations as a growing DOJ target.
On Feb 27, 2026, the EU Commission issued its first Research Security Monitor plus a Council Recommendation on science diplomacy, adopted May 29, 2026.
ROR’s March 2026 recap of its Annual Community Meeting reports that nearly 20% of the 8,000+ organization records added in 2025 are in East Asia, and confirms ‘single search’ becomes ROR’s default affiliation-matching strategy in 2026. A separate, unrelated ROR post the same month marks the registry’s 7th anniversary with a POSI commitment update.
ARC’s 5-goal PID Action Plan — DOIs on grants, ROR on institutions, ORCID on personnel, plus a FAIR data policy — is due complete by end of 2026.
DMPTool is rebuilding on a modern API architecture for machine-actionable DMPs. Its summer 2026 target has slipped to late 2026 after NIH/NSF changes.
FDA’s Dec. 2025 guidance pushes sponsors to justify restrictive eligibility criteria, distinct from and broader than the FDORA diversity action plan mandate.
ARPA-H’s Advancing Clinical Trial Readiness (ACTR) initiative aims to put a clinical trial site within 30 minutes of 90% of eligible Americans. Here’s what the program covers, its three funding focus areas, and where it stands.
DORA published a Practical Guide to Responsible Research Assessment for funders, with GRC and Science Europe, launched via regional events 13-14 May 2026.
Northwestern paid $2.3M under HHS-OIG’s Civil Monetary Penalties Law after self-disclosing a Feinberg researcher’s falsified NIH grant data.
Texas HB 127 (not SB 1565) sets an August 2026 research-security certification deadline for Texas public university boards.
ORCID has published ORCID 2030: Advancing the Future of Research, its strategic plan for 2026-2029, built around five themes: empowering researchers, connecting research information, broadening its community, advancing trust and integrity, and strengthening its own resiliency. Here’s what the plan actually says and what it signals for research administrators.
Software Heritage marked 10 years in Jan 2026, gained UNESCO/DPGA digital-public-good status, and struck a Sovereign Tech Agency archival partnership.
NIH has folded replication and reproducibility into its 2026 Gold Standard Science agenda: a new agency-wide Highlighted Topic, continued Common Fund replication funding, and an RFI on rewarding rigor in review. Here’s what’s actually new versus the existing 2016 rigor policy, and what it means for grants and data management offices supporting NIH-funded investigators.
EACL 2026’s call for papers confirms that submissions missing a dedicated Limitations section are desk rejected without review — a completeness check, not a quality judgment, that flows from ACL Rolling Review’s shared policy across the ACL, EMNLP, and NAACL submission pipeline.
As of January 2026, Quebec’s FRQ requires the narrative CV-FRQ for all its competitions, replacing the Canadian Common CV across all FRQ-funded programs.
Clarivate’s 2026 Journal Citation Reports gave 521 journals a Journal Impact Factor for the first time, from 47 countries/regions, with 58% based outside the US and Western Europe — part of a multi-year geographic-diversification trend research offices should track.
NIH’s RFI NOT-OD-26-086 proposes capping how many Research Project Grants one PI can hold at once. Comments closed August 3, 2026; no final policy yet.
In April 2025, NEH terminated more than 1,400 grants worth over $100 million; a federal judge has since ruled the mass termination unconstitutional. Starting June 30, 2026, NEH began asking each affected recipient to formally reconfirm, via a Reinstatement Assurances Form, that they still want the award back.
GAO: 5 top research-funding agencies havent assessed whether security screening risks discriminating against Chinese and Asian-descent scientists.
The House-passed DETERRENT Act would cut the Section 117 foreign-gift threshold to $50,000. A 26-group coalition pushed the stalled Senate bill in May 2026.
Cornell University Library relaunched eCommons on DSpace-CRIS, hosted by 4Science on AWS, on May 18, 2026 — a real institutional CRIS-migration case study.
AfriGen-D, a pan-African human genomics data hub, launched May 7, 2026, led by UCT, Institut Pasteur de Tunis, and University of Mauritius.
Duke University Libraries has completed migrating its Research Data Repository from the Hyrax/Samvera stack to TIND RDM, a platform built by CERN spinoff TIND, adding a submission dashboard, dataset versioning with new DOIs per version, file preview, and expanded ORCID/ROR support while preserving existing DOI resolution.
BIOSECURE Act became law Dec 18, 2025 (NDAA Sec. 851), restricting federal contracts and grants tied to designated biotechnology companies of concern.
The EU’s February 2026 Research Security Monitor and forthcoming Centre of Expertise add EU-wide policy coordination beyond Horizon Europe grant screening.
A Nov. 2025 OpenReview bug exposed ICLR 2026 reviewer identities, enabling bribery and harassment amid separate reports that 21% of reviews were AI-generated.
A February 2026 study surveyed 375 North American accounting researchers on 44 debatable research and authorship practices, mapping where field norms diverge.
A 2026 accounting change requires NIH to obligate a multi-year grant’s full cost up front instead of year-by-year, shrinking how many new awards its budget can fund. Reported figures show R01-equivalent awards down roughly 24% year-over-year, overall success rates falling toward the high-teens (lowest in decades per some trackers), and NCI applicant odds reportedly falling from about 1-in-10 to about 1-in-25.
Argentina’s INPI Resolution 38/2026 simplifies technology transfer agreement registration under Law 22,426, easing tax-relevant filings for global licensors.
Nigeria’s Federal Executive Council approved the National Intellectual Property Policy and Strategy (NIPPS) on November 6, 2025, and the government launched implementation on December 17, 2025. Here is what the framework actually changes for university IP commercialization and technology transfer offices.
From 1 April 2026, UKRI no longer accepts uninvited resubmissions of rejected proposals. Here is what changed and how it reshapes grant-writing strategy.
OpenAlex now ingests DataCite’s funder and grant metadata daily, part of a $3.6M Wellcome grant to build open funding infrastructure.
EO 14411 (June 22, 2026) tightens research-security and export-control coordination for quantum research. What it means for QIST funding and tech transfer.
In June 2026, Cambia sold The Lens to a new Australian non-profit under SPIE. Here’s what changes, and what does not, for Lens.org researchers.
ResearchGate retired the opaque RG Score around 2022 for the Research Interest (RI) Score, a formula weighting citations, recommendations, and reads.
Korean universities lead on paper counts but lag on citation impact and R&D return. NRF data, a Springer Nature forum, and researcher surveys are fueling a live debate over moving past publication-count evaluation.
Crossref’s 2026 public data file shows ROR IDs up 250% and grant-identifier links reaching 50,000 records, alongside its first Latin America Metadata Sprint.
Danish researcher Poul Thorsen was extradited from Germany after 15 years as a fugitive and arraigned on 22 federal wire fraud/money laundering counts.
The Supreme Court declined to hear Thaler v. Perlmutter (March 2026). What the human-authorship rule now means for CRediT, ICMJE, and AI disclosure practice.
AGU’s 2024 authorship update asks researchers to name local collaborators as co-authors, not just acknowledgments. Here is what changed and why it matters.
CAPES and Springer Nature have signed a three-year transformative agreement (Jan 2026-Dec 2028) giving authors at 400+ Brazilian institutions APC-free open-access publishing in 1,730+ hybrid journals and reading access to 1,770+ titles.
MALMAD, Israel’s national open-access consortium renewed its deal with The Company of Biologists through 2028, part of a staggered publisher portfolio.
Wolters Kluwer retracted nine transplant papers in July 2026 over unresolved organ-sourcing ethics tied to a 2019 scoping review.
Denmark’s NORA research portal moved from DTU to Statistics Denmark in Jan. 2026, ahead of a reported consolidated, open-architecture database later in 2026.
ASTM’s Journal of Testing and Evaluation retracted ~166 papers after a vendor found compromised peer review in guest-edited special issues.
A 2026 Accountability in Research study tracks faculty-student authorship-ethics views and tests whether training plus policy closes the gap.
In May 2026, arXiv began enforcing a one-year submission ban for authors whose papers show unchecked AI-generated content — hallucinated references or leftover chatbot text. Here’s what triggers it, how it’s enforced, and what it means for author accountability.
Dana-Farber paid $15M in Dec. 2025 to settle a DOJ False Claims Act suit over manipulated images in NIH-funded papers, and what it means for grant compliance.
The PREVAIL Act would tighten PTAB patent-challenge rules, but 2026 progress has stalled in committee — what it means for university TTOs.
Poland is overhauling how universities are scored, replacing rigid publication-point quotas with a two-pillar model adding qualitative criteria.
ERC restructured its 2026 Scientific Proposal: Part I (5pp, concept) and Part II (7pp, implementation) replace B1/B2; feasibility now assessed in Step 2.
HHMI (2026) and Gates Foundation (2025) both push preprints, but neither strictly requires posting before submission — what each policy actually says.
In April 2026 the OECD published a policy brief, Reforming Research Assessment for Better Science, finding that assessment still relies on narrow metrics that undervalue collaboration, openness, and societal impact, and recommending governments treat reform as a national science-policy priority.
CAUL reached in-principle 2026 open-access deals with Taylor & Francis, Springer Nature, Wiley, and, after stalled November talks, Elsevier.
CRKN, Canada’s national library consortium, is negotiating 2026 licenses with Elsevier, Sage, Springer Nature, T&F, and Wiley on cost and transparency.
Agents4Science 2025, organized by researchers at Stanford and Together AI, ran as a one-day virtual conference on October 22, 2025 with an unusual submission rule: an AI system had to be the paper’s primary author, generating the hypotheses, running the experiments, and writing the manuscript, with a human listed as a supervising co-author. It is one of the most concrete tests to date of how authorship credit and disclosure norms hold up when the ‘researcher’ doing the work is an AI agent.
The SAFE Research Act would have cut federal funding over ‘hostile foreign entity’ ties. University pushback got it struck from the FY2026 NDAA.
How researchers access LSST data: Rubin Science Platform accounts, data-rights eligibility, and Data Preview 2’s July 2026 rollout and two-year embargo.
A 2026 bibliometric analysis of roughly 480,000 PubMed and PMC records (2010-2024) finds equal-contribution tags climbing from a median of about 19% of articles in 2015 to over 30% in 2024, with China driving most of the growth.
Sweden’s Bibsam Consortium, coordinated by the National Library of Sweden, has adopted an action plan to stop signing hybrid read-and-publish agreements from 2026 onward, negotiating only with fully open-access publishers instead — following a 2023 SUHF recommendation on moving beyond transformative agreements.
HHS’s Simpler.Grants.gov initiative has shipped a new default search, account and submission-tracking tools, and a public API through 2025-2026 — but full application submission and a legacy Grants.gov retirement date are not yet confirmed. Here’s what’s actually changed for applicants.
A Walsh Medical Media journal published a commentary under a University at Buffalo researcher’s name without his knowledge, then demanded EUR400, later EUR499, before it would remove the false byline — and ultimately just swapped in a different, unverifiable author name instead. Retraction Watch’s March 2026 report ties the publisher to OMICS International, fined over $50 million by the FTC in 2019.
Switzerland had no national Springer Nature contract from Jan-June 2026. A new 2026-2029 Read & Publish deal, signed 10 June 2026, adds Gold OA.
CERN will operate the next phase of Open Research Europe from autumn 2026, backed by roughly €17 million in funding from 16 agencies across 11 European countries. Authorship eligibility expands beyond EC-funded researchers, but the diamond OA model — free to publish, open post-publication peer review — stays the same.
ROR retired version 1 of its API and metadata schema in December 2025. Here is the actual timeline, what changed in schema v2, and what to check if your institution has any ROR-consuming integration.
CRediT taxonomy translations now cover 35+ languages via a community project, not an official NISO release — what it means for non-English journals.
Zochi (Intology) and Sakana’s AI Scientist each passed real peer review in 2025 — one at ACL, one at an ICLR workshop. What it means for authorship.
Between late 2025 and early 2026, arXiv tightened endorsement (no more institutional-email-only qualification), required full English-language versions of every submission, and began requiring documented prior peer review for CS literature surveys and position papers after a flood of AI-generated submissions.
Gates Foundation, Novo Nordisk Foundation, and Wellcome launched Gr-ADI in January 2026 with $60 million for 18 antibiotic-discovery projects in 17 countries — the first major investment inside their broader $300 million global-health R&D partnership, and a notable model for joint-funder consortium grant terms.
University of Melbourne has opened a formal probe into education researcher John Hattie over alleged plagiarism and fabricated AI-style citations.
Frontiers retracted 122 articles after uncovering a ~35-author peer-review collusion network with undisclosed COI and citation manipulation.
Commerce cut, then restored, foreign access to Anthropic’s Fable 5/Mythos 5 over a jailbreak claim — what it means for research-security compliance.
UKRN’s STAR Study (Working Paper 12, July 2026) finds UK universities have built open-data policy and repository infrastructure since 2016, but adoption remains compliance-driven and has stalled — here’s what it found and recommends.
A rejected economics paper was resold on Telegram as authorship slots for as little as $55, published, then retracted — a documented paper-mill tactic.
The Netherlands fully revised its National Knowledge Security Guideline on 9 July 2026, updating the threat assessment and adding a risk-indicator appendix.
Norway retired Cristin during 2025 in favor of NVA (Nasjonalt vitenarkiv, the Norwegian Research Information Repository), a single national system operated by Sikt that also absorbed 60-plus institutional repositories, including BORA. Here is what changed for researchers and administrators.
The EU Council reached a partial position on FP10 (2028-2034) on 26 June 2026: EUR175bn proposed, four pillars. Here is what is agreed vs still open.
Peer Review Week 2026 runs Sept 14–18 under the theme “Peer Review Capacity: Volume, Speed, and Quality.” What it means for reviewers and publishers.
Bibliometric data show single-author systematic reviews climbing steadily since 2000 — including inside Cochrane’s own database — despite guidance calling for independent dual-reviewer screening.
2025 bibliometric studies show women’s senior- and corresponding-authorship share still lags first-authorship gains, with implications for research policy.
In January 2025, CNR convened Italy’s 1st National Congress on Research Integrity in Rome, producing the Declaration of Rome. CASRAI covers the CNR committee behind it, the Congress, and the national oversight gap the Declaration itself names — including the proposed National Observatory of Research Integrity.
Senate Judiciary July 14, 2026 hearing on PERA (S.1546) weighed patent eligibility for diagnostics and AI — key stakes for university tech transfer.
Elsevier expanded Check Integrity to nearly 2,000 journals in March 2026, flagging unauthorized authorship changes and editorial conflicts of interest.
Sheffield, Lancaster, Surrey, Essex, Kent, Sussex, and York declined Elsevier’s 2026 deal after Jisc’s national negotiation cycle, citing unsustainable costs.
MOST Order No. 24 lists 68 categories of research misconduct across six actor types, part of China’s push to hold institutions accountable.
The EDPB’s draft Guidelines 1/2026, published 15 April 2026, set out a six-factor test for “scientific research” under GDPR and detail Article 89 safeguards, legal bases, and a restrictive line on data-subject-right derogations. Consultation closed 25 June 2026; the text is not yet final.
euroCRIS’s 17th CRIS Conference (CRIS2026) drew 112 attendees to the University of the Azores in May 2026, covering open science, interoperability, and AI. A recap of what happened and why it matters for CRIS managers.
MIIT’s revised technology contract registration rules, effective March 1 2026, tie VAT/CIT tax breaks to registered transfer, licensing, and R&D contracts.
China’s Ministry of Science and Technology has ordered universities to investigate retracted papers for misconduct and warned of penalties for looking away.
PTAB again ruled Broad/MIT/Harvard, not UC Berkeley’s CVC, invented eukaryotic CRISPR-Cas9 first — reaffirming priority on Federal Circuit remand.
Canada’s PRCR ran a Feb 17-Apr 17, 2026 consultation proposing to remove any statute of limitations on research misconduct allegations, alongside new rules on anonymous complaints, post-departure accountability, and retaliatory-allegation protections. The comment period has closed; no revised Framework has been published yet.
Commerce opened a Bayh-Dole march-in proceeding against Harvard’s patents in Aug. 2025 — the first agency-initiated test of march-in rights.
FDA’s Commissioner’s National Priority Voucher (CNPV) pilot promises a one-to-two-month review for drugs meeting national health priorities. Here’s how it differs from statutory Priority Review Vouchers, who has received one, and where the program stands as of FDA’s 2026 public hearing.
Crossref has published its first position paper, arguing that national and international PID policy focused narrowly on identifiers misses what actually makes research infrastructure work: open linked metadata and sustainably governed organisations. The paper offers five recommendations for policymakers and draws worked examples from the UK, Portugal, Canada and South Africa.
Since October 1, 2025, applicants for commercial patent licenses on NIH-owned (intramural) inventions must submit an access plan addressing affordability, availability, acceptability, and sustainability. It does not apply to university-owned inventions from NIH-funded (extramural) research — here’s what tech-transfer offices need to know about scope, requirements, and the effective date.
Health Canada’s draft Clinical Trials Regulations and its April 2026 ICH E6(R3) adoption mark Canada’s biggest trial-oversight overhaul in decades.
FDA’s June 22, 2026 revised draft guidance clarifies when a single adequate and well-controlled trial plus confirmatory evidence can satisfy the substantial-evidence-of-effectiveness standard for drug and biologic approval, narrowing the traditional two-trial default. Comments are open through September 22, 2026.
FDA published draft guidance Jan. 12, 2026 setting expectations for Bayesian primary-analysis designs in drug/biologic trials. Comments closed March 13, 2026.
A second 2026 wave: editors left journals at Springer Nature, Wiley, and Taylor & Francis over volume quotas, publisher control, and open-access disputes.
CMS and FDA launched RAPID on April 23, 2026, targeting Medicare coverage within 60-90 days of FDA authorization for breakthrough devices, pausing TCET for new candidates.
The 3rd Global Summit on Diamond Open Access (Bengaluru, Feb 2026) produced a six-pillar global roadmap for OA policy, funding, and evaluation reform.
A D.D.C. court granted summary judgment for HHS on Dec. 12, 2025, upholding ORI’s misconduct findings and 3-year debarment of researcher Ivana Frech.
Elsevier, Springer Nature, and Taylor & Francis journals saw mass editor resignations in 2026 over governance, an APC mandate, and referee load.
FDA’s final guidance sets trial-design rules for psychedelic drug studies, addressing functional unblinding and abuse-potential testing.
NSF restarted SBIR/STTR for FY26 with $250M, a new $30M Strategic Breakthrough tier, a $40M instrumentation pilot, and a July 27, 2026 deadline.
On July 14, 2026, FDA finalized guidances on generic topical corticosteroid bioequivalence testing and formal FDA meetings for OTC monograph drug sponsors.
University of Zurich cleared neuropathologist Adriano Aguzzi of misconduct, but flagged 7 of 36 studies for image errors he must now retract or correct.
A new dataset, BuyTheBy, quantifies for the first time what paper mills actually charge for authorship: 18,710 ads, prices from roughly $56 to $5,631 for first-author slots, and just 5 of 53 matched published papers retracted so far.
COPE’s new Code of Conduct for members is live, replacing the retired 2024 Core Practices, with a 12-month transition before adherence is mandatory.
South Korea’s National Research Foundation found no research misconduct in Changwon National University president Park Min-won’s papers, closing a three-year plagiarism and duplicate-publication review.
ICML 2026 used hidden PDF watermarks to catch 506 reviewers using AI, desk-rejecting 497 papers tied to 398 of them amid a record 23,918 submissions.
China’s National Health Commission disclosed 28 sanctioned misconduct cases spanning data fabrication, paper trading, and guest authorship.
HORIZON-ZEN+, a CERN-coordinated EU project (2025-2027), adds AI-assisted curation and discovery tools to Zenodo’s EU Open Research Repository.
ICML 2026 study: AI peer-review scores can be gamed by cosmetic ‘paper laundering’ rewrites, a risk authors warn could disadvantage novel work.
UHERO withdrew a Hawaii electricity-policy report in July 2026 after its author found an AI assistant had inverted a key solar-pricing trend from a Berkeley Lab dataset, unverified before publication — a live case study in AI-disclosure and verification gaps.
The European Commission convened 28 EOSC Nodes and 34 Horizon Europe EOSC projects in Brussels, July 7-9, 2026, marking 14 new Nodes and ~€500M in investment.
OMB’s proposed grants rewrite would give political appointees final sign-off and recast peer review as advisory. Comments closed at 340,000+.
NIH is centralizing peer review of fellowship (F), career development (K), and training (T) applications, giving more weight to candidate potential and training goals — part of its broader Unified NIH Funding Strategy.
CMS’s CY2027 fee schedule proposal narrows, not bans, third-party RPM/RTM billing. Here is the real mechanism, the OIG data behind it, and what it means for clinical trial billing compliance.
OSTP’s July 2026 report and FY2028 memo direct agencies to fund researchers over institutions and diversify grants beyond peer review.
Wiley is investigating a peer reviewer accused of demanding payment to approve a manuscript at journal Security and Privacy.
AHRQ has issued near-identical “non-award” letters ending continuation funding for dozens of active grants, citing portfolio prioritization. HHS says these are not terminations; grantees and advocacy groups disagree, a distinction with real consequences for appeal rights and sponsored-programs planning.
UKCORI co-lead Miles Padgett told the UK Reproducibility Network conference the committee has no operations planned beyond 2027, and sketched a scenario for a new centralised UK research-integrity body — not yet a confirmed policy.
Five researchers, including Harvard geneticist George Church, were moved off a Nature Methods byline into acknowledgements amid U.S. scrutiny of China ties.
A Tufts historian’s award-winning book failed an external peer review. The AHA rescinded her prize; she’s no longer at Tufts and disputes the findings.
ERC Work Programme 2027: wider Starting/Consolidator eligibility windows, one-proposal limit, plus Consolidator Grant 2027 call dates (24 Sep 2026–12 Jan 2027) and funding.
Wellcome revises grant eligibility from 1 July 2026 and restricts lead-applicant hosts to the UK and LMICs in Africa, South and SE Asia from 29 October 2026.
Springer Nature reports nearly 40% of citations to China’s 2022 gold OA articles now come from outside China, while a separate June 2026 announcement puts its EU open-access agreement coverage at 74% of member states, including renewed Czechia, Greece, and Finland deals.
How NorthStrive Defense Tech’s exclusive FSU drone-payload license moved from option (Apr 2026) to term sheet (Jun) to signed license (Jul 2026).
ALZAI Health took an exclusive, worldwide license to AI liver-risk tech from Yeda (Weizmann) and MOR (Clalit) — a royalty deal, not equity.
Rutgers University is investigating whether payments its own units made to Dean Jacqueline Mattis’s writing-retreat company, Easton’s Nook, violate New Jersey conflict-of-interest law. Reported totals range $145K-$155K over about nine years; the probe is ongoing.
Sage retracted 8 papers by ex-editor Yannick Griep for self-reviewed peer review; Radboud separately confirmed data fabrication.
ORCID and China’s CSTR Identification Platform signed an MOU on July 16, 2026 to pursue interoperability between their persistent identifier systems. No technical implementation details have been published yet; here’s what the agreement covers and why CRIS and research-administration teams working with Chinese research partners should watch it.
A new Learned Publishing study finds 83% of high-impact journals have explicit AI peer-review policies, versus 75% of mid-tier titles.
On 16 July 2026, Springer Nature launched Nature Books, a new imprint that lets authors publish long-form work under the Nature brand for the first time. It sits alongside Springer and Palgrave Macmillan within Springer Nature’s roughly 14,500-title-a-year book business, with proposals guided by an editorial board of in-house Nature Portfolio editors before commissioning, peer review, and production move to Springer Nature’s existing books teams.
A 2.7-million-preprint IEEE S&P 2026 study found 88% of arXiv submissions leak hidden source-file data: passwords, API keys, GPS coordinates.
Nobel laureate Thomas Südhof told Lindau 2026 that publishing is unregulated, dismissed COPE as self-serving, and urged a government “FDA for journals.”
A March 2026 ORI finding against former Mount Sinai postdoc Chen-Yeh “George” Ke — for falsified images in a draft manuscript and NIH progress reports — prompted independent image-forensics sleuthing of his broader publication record. That work surfaced an unrelated duplicated image in a 2019 Science Signaling paper, which the journal retracted in July 2026 after finding further discrepancies.
FDA reopened comment on its master protocol draft guidance in June 2026, adding new basket-trial recommendations. Comments are open through August 24, 2026.
ORI’s final rule revising 42 CFR Part 93 took effect Jan 1, 2025 and applies to allegations received on or after Jan 1, 2026. Here’s exactly what changed.
NSF 26-022 bars NSF-funded collaboration with entities on seven federal restricted-party lists, starting FY2027. Here’s what it does and doesn’t cover.
In 2026, the University of Alberta, University of Delaware, and University of British Columbia each ended a major bundled journal subscription — with Springer Nature, Wiley, and Sage respectively — citing publisher price increases that have outpaced flat collections budgets. Here’s what each library actually announced, and what changed for researchers.
On July 1, 2026, arXiv left Cornell University’s umbrella to become arXiv, Inc., an independent 501(c)(3) nonprofit. Cornell and the Simons Foundation are founding Members with board seats on a 12-member board; a $10M Simons/Schmidt Sciences gift funds cloud migration. The arxiv.org URL, free access, staff, and moderation process are unchanged.
OMB’s May 2026 proposed rule would bar federal grant funds from collaboration with “covered foreign countries.” Here’s what the rule’s text actually says, why the widely-cited “17 countries” figure isn’t a real OMB list, and how this differs from the CHIPS Act’s countries-of-concern list.
BIS’s 2026 settlements, led by a record $252.5M Applied Materials case, reveal what triggers export-control violations for research institutions.
COGR’s June 2026 meeting included a GAO briefing flagging research security as a top oversight area. What’s confirmed, and what it means for research admins.
GAO-26-107738 (May 2026) found 2 of 9 agencies lacked a public-access policy, reuse-rights gaps at NSF/USDA, and costs it warns could reach $1B/year.
Executive Order 14292 (May 2025) paused federal funding for dangerous gain-of-function research and set OSTP deadlines for oversight rules, now overdue.
MA3 (Modernizing Academic Appointment & Advancement) is a US-specific research-assessment reform initiative, distinct from DORA and CoARA: it funds a defined cohort of universities to actually rebuild hiring, review, promotion, and tenure processes rather than sign a statement of principle. Here is what it is, who runs it, and where it stands.
A March 2026 law-firm alert warns the fundamental research exclusion is quietly narrowing for universities. No BIS or Federal Register rule change was found to confirm that framing — here’s what’s actually enacted (NSPM-33, Section 117, the BIOSECURE Act) versus what’s still just a warning.
FDA’s proposed Expedited IND Pilot Program would speed first-in-human trials via Qualified Research Institutions; comments now due Aug. 24, 2026.
NIH Notice NOT-OD-26-064 ends Continuous Submission after August 10, 2026, and narrows late-application eligibility for all applicants NIH-wide.
ARC’s updated Open Access Policy took effect 1 July 2026: immediate OA for articles, a 12-month window for books, and new Indigenous research provisions.
NIH’s 15% indirect-cost cap is dead: the First Circuit upheld the injunction against it in January 2026, and DOJ let its Supreme Court appeal deadline lapse in April 2026 without filing. Congress has separately blocked equivalent caps at NIH, DOE, and NSF through appropriations riders. The remaining risk isn’t litigation — it’s the annual budget-request cycle.
FDA has initiated two proof-of-concept real-time clinical trials and opened an RFI on a broader RTCT pilot program. Final selection criteria are expected in July 2026, with pilot selections completed in August 2026.
NSF named 12 new Regional Innovation Engines across 20 states on July 14, 2026, each eligible for up to $160M over 10 years.
OMB’s proposed rewrite of the Uniform Guidance (2 CFR 200) closed for comment July 13, 2026. What it would change, and its status toward an Oct. 1 target.
The ARC’s updated Generative AI policy took effect 28 April 2026, setting rules for applicants, assessors, and research offices.
US university budget cuts and layoffs have continued into summer 2026, with new rounds at Johns Hopkins, the University of Minnesota, The New School, and others. Some are explicitly tied to NIH, NSF, and USAID funding disruption; others are driven mainly by enrollment or state-funding pressure. Here’s what’s documented, institution by institution.
CIHR, NSERC, and SSHRC’s revised Tri-Agency Guide on Financial Administration takes effect April 1, 2026. The key change: a new Buy-Canadian purchasing expectation for grant-funded spend, plus a tighter rule on consulting fees paid to grant-team-affiliated entities.
Effective June 1, 2026, NIH requires prior approval before adding a new domestic subaward not in the original approved application.
Hachette, Cengage, Elsevier, and Scott Turow sued Google in SDNY, alleging Gemini trained on Google Books, Play Books, and Scholar without authorization.
NSF’s PAPPG 26-200 supplement (eff. Dec. 8, 2025) revised SBIR pitch rules, funding caps, equipment thresholds, and research-security requirements.
ED’s Feb. 23, 2026 pact with State adds national-security review to Section 117 foreign-gift oversight. Thresholds and deadlines are unchanged.
Retraction Watch’s database has logged over 63,000 retractions. In April 2026 congressional testimony, RW cited a current 0.2% overall retraction rate.
COPE relaunched its paper mills working group in June 2026, citing AI-exploited coordinated misconduct as the driver, with a companion toolkit to its systematic-manipulation guidelines as the group’s first stated deliverable.
NIH triaged applications into discussion tiers to clear its shutdown backlog; a related funding-criteria shift drew reported political-influence concerns.
Federal agencies now require ORCID as a digital persistent identifier; universities are setting their own 2026 linkage deadlines ahead of enforcement.
Wiley will launch eight new journals under its “Advanced” brand by the end of 2026, expanding beyond materials science into oncology, AI, robotics, and chemical engineering. For researchers and research administrators, the practical questions are the ones the launch announcement doesn’t answer: none of the new titles will have a Journal Impact Factor for at least two years, and Wiley has not disclosed open-access status or APCs for any of them.
NIH’s Common Forms leniency period ended May 8, 2026: eRA now blocks SciENcv biosketch/support submissions with unlinked ORCID or eRA Commons.
A new analysis of the Retraction Watch Database (1997-2026) finds Elsevier has the lowest normalized retraction rate and by far the highest reinstatement rate among ten major publishers — with a caveat from the study’s own author about what that actually measures.
STAT’s April 2026 investigation traces BMJ’s retraction of 7 of 8 papers in a guest-edited Journal of Medical Genetics issue, and the pattern behind it.
NIH’s May 2026 notice explains when AI use in funded research crosses into research misconduct, and what enforcement follows.
REF 2029 criteria-setting paused 4 Sept 2025, resumed 10 Dec 2025: CKU/E&I/SPRE weightings, a 5-output cap, and lighter impact rules are now confirmed.
The US Office of Research Integrity’s 2026 case summaries include a 15-year debarment of former Rice University professor Ariel Fernandez for fabricating data across 12 published papers — one of ORI’s longest debarment periods on record. Alongside two other 2026 cases, it shows an active federal misconduct-enforcement pipeline continuing to work through cases under the current, recently revised 42 CFR Part 93 framework.
cOAlition S’s Strategy 2026-2030 widens accepted open-access routes beyond Plan S’s original three, deferring rule changes to a 2026-2027 review.
NSPM-33’s $50M research security program deadline isn’t one fixed July 2026 date — it’s agency-specific. Plus DoD’s Jan. 2026 memo, explained.
The European Commission adopted Horizon Europe’s 2026-2027 Work Programme on 11 December 2025: EUR 14bn, at least 35% for climate, and a new valorisation push.
DHS ends open-ended F-1/J-1 admission on Sept. 15, 2026, capping it at up to 4 years with a separate USCIS extension filing – and the rule is now being challenged in court.
ClinicalTrials.gov is retiring the Classic Protocol Registration and Results System (PRS) in stages through 2026 and 2027, moving every sponsor and registrant onto the Modernized PRS. Here is the confirmed timeline, from the July 2026 cutoff on new records to the Fall 2026 submission deadline, and what to do before each one.
Where Harvard’s federal research funding fight stands in 2026, and why the appeal’s jurisdictional question matters for every funded institution.
Federal judge Rita Lin has repeatedly ordered NSF and NIH to restore suspended UCLA grants via preliminary injunction in an ongoing UC faculty lawsuit — roughly $81M (NSF, Aug 2025) and $500M/500 grants (NIH plus DOD/DOT/HHS, Sept 2025). As of July 2026 the case is still open toward a final ruling, with a hearing set for October 20, 2026. Here is what “restored” by preliminary injunction means operationally for a research office — and why it is not the same as a resolved dispute.
A 2026 status map of Accord implementation: HELP/HECS reform now law, university funding mid-transition, ATEC on its own legislative track.
MDPI’s multi-year Proofig AI deal and ASM’s Imagetwin pilot data show AI image-forensics screening becoming standard in publisher editorial workflows.
The 2022 Nelson Memo required every federal funder, not just NIH, to adopt zero-embargo public access by Dec. 2025 — here’s where agencies stand in 2026.
Congress rejected the White House’s FY2026 proposal to eliminate the Fogarty International Center, funding NIH’s global health research arm at $95 million — flat with FY2025. Here’s the current status.
Wiley disclosed $49M in FY2026 AI licensing revenue ($110M lifetime). Taylor & Francis and Springer Nature show similar deals; small publishers see little.
A Feb. 2026 C&EN investigation found citation cartels inventing fake author identities and misusing APC waivers to sell undetectable citation boosts.
The FY2026 Labor-HHS appropriations report directs HHS to process grant disbursements within 5 business days, with exceptions. What NIH awardees should know.
A PNAS study of 5.2M papers found 70% of journals have AI policies, but only ~0.1% of papers actually disclosed AI use.
ICMJE updated its Recommendations in January 2026, adding a new standalone Section V on AI use and a new Section III.L.2 on authors’ access to trial data, plus revisions to sponsor-agreement, misconduct, trial-registration, and funding-disclosure guidance.
UKRI’s 22 June 2026 FAQ update clarifies Horizon Europe Guarantee compliance and block grants, part of a 2026-2030 Open Access Monitor plan.
NeurIPS 2026 desk-rejected 178 position papers (18.4%) via the Pangram AI detector, no appeal allowed. What is verified, what is disputed, and why it matters.
Congress rejected NIH’s 27-to-8 institute consolidation in FY2026 funding, but administrative restructuring continues. Here’s the current status.
Where 2026 litigation over SEVIS record terminations and visa revocations stands, and what it means for international researchers.
The 2025 H-1B $100,000 fee hits new petitions requiring consular processing, including at universities. Litigation is ongoing — current status inside.
NSF’s indirect cost cap attempt was blocked and Congress has barred new rate changes. Grant terminations tied to DEI/environmental-justice criteria are being litigated on two separate tracks with different outcomes so far, and NSF’s budget remains under pressure. Here is the current, still-moving status as of mid-2026.
NCI’s FY2026 budget was proposed for a 37-43% cut; Congress instead raised NIH overall slightly, but cancer grants are still funded below recommended levels.
A New York court reversed a student’s expulsion over a Turnitin false positive, and universities are switching AI-writing detectors off. The 2026 landscape.
NIH terminated its Minority Biomedical Research Support Program and froze diversity supplements in 2025 – what was cut, and where litigation stands now.
Congress rejected Trump’s proposed 40% NIH cut in FY2026, funding NIH at $48.7B — but grant terminations and indirect-cost fights still reshaped awards.
Where CASRAI is headed in 2027: priorities for the Dictionary, the federation work, CRediT v3 discussions, and the integration roadmap.
Suspect-paper triage at scale needs structured signal escalation. A practical model for moving manuscripts from orange-flag screening to red-flag investigation.
Five major journals’ GenAI disclosure wordings, side by side. What each requires, where they differ, and the practical implications for authors.
Institutional CRediT capture has a fixed-cost-versus-recurring-cost crossover. A practical model of where the tipping point lies and how to reach it faster.
The integrity community’s debate on how to engage with paper mills: confrontation, infiltration, or harm reduction. A look at what is actually working.
A 2026 audit of how the top-100 cited journals collect CRediT at submission. Coverage is up, but qualifier capture and JATS fidelity remain uneven.
A preview of the v2026.3 CASRAI Dictionary release: scope, new terms, deprecations, and the schema-evolution work threading through the update.
Reproducibility checklists at submission have proliferated. A walkthrough of the major ones, what they catch, and what authors should do to satisfy them efficiently.
A practical four-week implementation plan for a library-run CRediT helpdesk, with staffing, materials, workflows, and the first-month playbook.
NSF Notice 149 makes research-security training, MFTRP, and Confucius Institute certifications mandatory for proposals, effective Dec. 2, 2025.
ACM is creating its first director of research integrity role to clear a case backlog, joining Springer Nature and Elsevier in treating misconduct investigation as a dedicated, professionalized function rather than a volunteer committee job.
NIH’s April 2026 notice NOT-OD-26-072 reinstates the $25,000 subaward cap and 10% de minimis rate, rescinding 2025 flexibilities — a separate action from the litigated 15% cost cap.
ORCID iDs are now required by most major funders for PIs and increasingly for co-investigators. A practical map of where the requirements bite in 2026.
Software citation in 2026 runs on a three-cornered stack. The roles of DataCite, GitHub, and Zenodo — and what integrators should do about the seams.
Open peer review is mainstreaming. The signals, identifiers, and attribution mechanisms that make it work — and the gaps that still need closing in 2026.
RAiD has moved from pilot to operational service in several jurisdictions. A status report on adoption, integration patterns, and the questions still open.
Should mentorship be a CRediT role? The case for, the case against, and a proposed mid-path that recognises mentorship without breaking the taxonomy.
CRIS systems are converging on interoperability but the three dominant data models still misalign. A practical guide to the CERIF-Pure-VIVO triangle.
The CASRAI website has moved to a modern headless stack — Next.js front, WordPress back, federated with NISO, euroCRIS, CODATA, RDA, ORCID, Crossref, DataCite and ARDC.
The first stable release of the modernised CASRAI Dictionary ships today: 714 entries across 20 domains, CC-BY 4.0, machine-readable in seven formats.
When AI generated parts of a paper, which CRediT roles apply to the humans who prompted and verified? A working line between disclosure and contribution.
When a paper’s main output is code, the CRediT Software role bears the load. A practical guide to assigning Software for code-only research outputs.
Carbon-aware scheduling, geographic shifting, and the practical work of cutting academic HPC’s emissions footprint. What clusters are doing in 2026.
Eighteen months after NSPM-33 disclosure requirements took effect, a status report on what worked, what is broken, and the institutional adjustments still pending.
Latin America’s Diamond OA infrastructures have run a successful model for two decades. What the rest of the world is finally learning from SciELO, Latindex, and AmeliCA.
FAIR maximises openness; CARE centres Indigenous sovereignty. A walkthrough of the GIDA Manifesto’s reconciliation framework and what implementers should do.
ICMJE authorship plus CRediT contributorship: a practical 2026 guide to the 14 roles, lead/equal/supporting qualifiers, JATS XML, and journal-specific expectations.
NSF didn’t rewrite Broader Impacts in 2026 — the real change is the April 2025 Statement of Priorities, still governing every 2026 proposal.
ICMJE rejects AI as an author; publishers require structured disclosure. A 2026 map of who asks for what, the hallucination problem, RAG, and watermark detection.
The PID quartet that anchors modern research metadata: how ORCID, ROR, RAiD, and DOIs interlock in 2026, and what’s still broken at the crosswalk layer.
RDA’s DMP Common Standard v2 reorganises the machine-actionable data management plan. A field-by-field walkthrough of what changed and why.
Plan S compliance, Diamond OA’s rise, S2O models, Read-and-Publish agreements, and the slow rebalancing of who pays for global scholarly publishing.
UKRI’s Resume for Research and Innovation has matured. Why other funders should adopt narrative-CV formats, and the practical lessons from five years of UKRI experience.
A practitioner’s tour of EQUATOR’s reporting guidelines, when each applies, FAIR4RS for software, and the registered-report turn in 2026.
The 2026 EOSC Federation governance refresh: new node-membership criteria, the sustainability funding model, and how integrators should reposition.
From DORA (2012) to CoARA (2022) to UKRI’s 2024 R4RI mandate: the slow institutional turn against the impact factor and toward narrative CVs.
What the EU AI Act actually requires of research administrators, where the exemptions sit, and the practical compliance checklist for institutions in 2026.
From PDF DMP to RDA-compliant maDMP: tooling, integration, and the new requirement for software-management plans alongside data plans.
Role inflation, byline-order confusion, and missing writing roles: the three recurring CRediT failures editors flag, with concrete examples and fixes.
RDA Maturity Model, F-UJI, FAIR-Aware, CESSDA, ARDC: which FAIR assessment tool to choose, when, and how to integrate with institutional repositories.
PRISMA’s 2026 revision adds AI-assisted screening, living review checklists, and machine-readable flow diagrams. What systematic reviewers need to update.
Data papers and software papers don’t map cleanly onto the 14 CRediT roles. A practical guide to the friction and where the taxonomy needs work.
Cabanac’s Problematic Paper Screener, retraction wave, citation cartels, COPE flowcharts, and the United2Act initiative: where the publishing-integrity fight stands.
LEAF awards, My Green Lab certification, freezer management, single-use plastics, sustainable HPC, conference travel: practical sustainability in the 2026 research lab.
The case for a 15th CRediT role covering AI assistance, the counter-arguments, and a draft scope statement for the CASRAI community to test.
Current and pending support, foreign-component disclosure, NIH Other Support, foreign-talent-recruitment programmes: the 2026 NSPM-33 compliance landscape.
Crossref Grants, the Funder Registry, and the long-awaited grant-to-output linkage. What CRediT integrators need to know to consume the new graph.
The CARE Principles, OCAP, Te Mana Raraunga, Maiam nayri Wingara, FPIC, and Traditional Knowledge Labels: integrating Indigenous data sovereignty alongside FAIR.
ORCID’s 4.0 IDR refresh tightens the contributor-affiliation-funding crosswalk. A walkthrough of what changes for CASRAI integrations and what publishers should do now.
